Literature DB >> 20505277

Small bowel perforation caused by Epstein-Barr virus-associated B cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma.

Tsutomu Takahashi1, Riruke Maruyama, Satoko Mishima, Masaya Inoue, Koshi Kawakami, Chie Onishi, Takaaki Miyake, Junko Tanaka, Toru Nabika, Hiroto Ishikura.   

Abstract

On rare occasions, secondary Epstein-Barr virus (EBV)-associated B cell lymphoma can develop in a patient with angioimmunoblastic T-cell lymphoma (AITL). We report a case of a 66-year-old Japanese woman who developed diffuse large B-cell lymphoma (DLBCL) in her small intestine after chemotherapy for AITL. She was found to have panperitonitis due to perforation of the small intestine. Partial ileectomy specimen showed DLBCL cells infiltrating into the intestinal wall. In situ hybridization for EBV-encoded RNA revealed positivity in the lymphoma cells. The lymph nodes diagnosed as AITL were negative for EBV infection and there was no coexistence of B cell neoplasms in them. We thought small bowel perforation in this case was caused by EBV-associated B cell lymphoma secondary to AITL. Our case showed a remarkable deficiency of cellular immunity after chemotherapy, which we postulate was related to the cause of occurrence of B-cell lymphoma.

Entities:  

Mesh:

Year:  2010        PMID: 20505277     DOI: 10.3960/jslrt.50.59

Source DB:  PubMed          Journal:  J Clin Exp Hematop        ISSN: 1346-4280


  8 in total

Review 1.  Development of angioimmunoblastic T-cell lymphoma after treatment of diffuse large B-cell lymphoma: a case report and review of literature.

Authors:  Yaya Wang; Bailu Xie; Yu Chen; Zhenqian Huang; Huo Tan
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

2.  Cerebellar EBV-associated diffuse large B cell lymphoma following angioimmunoblastic T cell lymphoma.

Authors:  Yi Zhou; Marc K Rosenblum; Ahmet Dogan; Achim A Jungbluth; April Chiu
Journal:  J Hematop       Date:  2015-03-18       Impact factor: 0.196

3.  Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist.

Authors:  Alina Nicolae; Stefania Pittaluga; Girish Venkataraman; Anahi Vijnovich-Baron; Liqiang Xi; Mark Raffeld; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2013-06       Impact factor: 6.394

Review 4.  Rare gastrointestinal lymphomas: The endoscopic investigation.

Authors:  Calogero Vetro; Giacomo Bonanno; Giorgio Giulietti; Alessandra Romano; Concetta Conticello; Annalisa Chiarenza; Paolo Spina; Francesco Coppolino; Rosario Cunsolo; Francesco Di Raimondo
Journal:  World J Gastrointest Endosc       Date:  2015-08-10

Review 5.  Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature.

Authors:  Qing-Xu Yang; Xiao-Juan Pei; Xiao-Ying Tian; Yang Li; Zhi Li
Journal:  Diagn Pathol       Date:  2012-01-19       Impact factor: 2.644

6.  Promising Response to Lenalidomide-Combination Therapy in a Discordant Lymphoma Consisting of EBV-Positive Diffuse Large B-Cell Lymphoma and Angioimmunoblastic T-Cell Lymphoma: A Case Report.

Authors:  Pan Hu; Yu Ben; Juan Liu; Weicheng Zheng; Xiyue Yan; Yaping Zhang; Wenyu Shi
Journal:  Onco Targets Ther       Date:  2021-04-12       Impact factor: 4.147

7.  Reconstitution of EBV-directed T cell immunity by adoptive transfer of peptide-stimulated T cells in a patient after allogeneic stem cell transplantation for AITL.

Authors:  María Fernanda Lammoglia Cobo; Julia Ritter; Regina Gary; Volkhard Seitz; Josef Mautner; Michael Aigner; Simon Völkl; Stefanie Schaffer; Stephanie Moi; Anke Seegebarth; Heiko Bruns; Wolf Rösler; Kerstin Amann; Maike Büttner-Herold; Steffen Hennig; Andreas Mackensen; Michael Hummel; Andreas Moosmann; Armin Gerbitz
Journal:  PLoS Pathog       Date:  2022-04-22       Impact factor: 7.464

8.  Case Report: Immune Microenvironment and Mutation Features in a Patient With Epstein-Barr Virus Positive Large B-Cell Lymphoma Secondary to Angioimmunoblastic T-Cell Lymphoma.

Authors:  Fen Zhang; Wenyu Li; Qian Cui; Yu Chen; Yanhui Liu
Journal:  Front Genet       Date:  2022-07-22       Impact factor: 4.772

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.